Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
Clinical trial NCT02243189 · TERMINATED
Trial details
- NCT number
- NCT02243189
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2014-12-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.